Kameda Takanori

Hasegawa Kei, Suda Kenji, Akagi Tadamichi, Ikeda Hanako Ohashi, Kameda Takanori, Miyake Masahiro et al.

Sun Chunxiao, Ikeda Hanako O, Miyake Masahiro, Suda Kenji, Kameda Takanori, Akagi Tadamichi et al.

This study found three ab interno trabeculotomy techniques offer similar IOP reduction and complication rates. Clinically, device choice doesn't significantly impact outcomes, but wider incisions increase hyphema risk.

Hara Tomoyo, Ikeda Hanako O, Numa Shogo, Miyake Masahiro, Suda Kenji, Kameda Takanori et al.

This study compared Ahmed and Baerveldt glaucoma implants in Japanese patients, finding similar IOP outcomes but more complications, especially hypotony, with Baerveldt, influencing device choice based on glaucoma type.

Suda Kenji, Miyake Masahiro, Akagi Tadamichi, Ikeda Hanako Ohashi, Kameda Takanori, Hasegawa Tomoko et al.

This study found longer axial length (≥27.7mm) correlates with advanced visual field loss in young POAG patients, highlighting its clinical significance for assessing severe glaucoma risk.

Kido Ai, Miyake Masahiro, Akagi Tadamichi, Ikeda Hanako Ohashi, Kameda Takanori, Suda Kenji et al.

This study found topical beta-blockers for glaucoma did not significantly increase asthma attacks in patients with asthma, suggesting they might be an option when other treatments fail.

Suda Kenji, Akagi Tadamichi, Ikeda Hanako Ohashi, Kameda Takanori, Hasegawa Tomoko, Miyake Masahiro et al.

Atopic dermatitis linked to severe visual field loss in younger glaucoma patients on steroids. This highlights the need for earlier, reinforced eye screening in atopic dermatitis patients.

Akagi Tadamichi, Uji Akihito, Okamoto Yoko, Suda Kenji, Kameda Takanori, Nakanishi Hideo et al.

AS-OCTA showed no overall vessel density difference in glaucoma eyes, but prostaglandin use and IOP affected superficial/deep vessel density, suggesting utility for assessing hyperemia and outflow pathophysiology.

Numa Shogo, Akagi Tadamichi, Uji Akihito, Suda Kenji, Nakanishi Hideo, Kameda Takanori et al.

OCTA visualized lamina cribrosa microvasculature, showing reduced flow in glaucoma. This novel imaging may help identify and understand glaucoma-related LC changes.

Nakanishi Hideo, Suda Kenji, Yoshikawa Munemitsu, Akagi Tadamichi, Kameda Takanori, Ikeda Hanako Ohashi et al.

This study found optic disc ovality linked to axial length and visual field loss in glaucoma, highlighting how eye shape influences disc assessment and disease progression.

Yamada Rika, Hirose Fumitaka, Matsuki Takaaki, Kameda Takanori, Kurimoto Yasuo

This study compared MPT and DRPPT for angle closure, finding MPT results better correlated with shallower anterior chambers, narrower angles, and thicker irises. This suggests MPT may be more useful for assessing angle configuration.

Kameda Takanori, Inoue Toshihiro, Inatani Masaru, Tanihara Hidenobu

Phaco-GSL effectively treats angle-closure glaucoma long-term, with success influenced by age, preoperative IOP, and postoperative LPI, guiding personalized treatment strategies.

Fujimoto Tomokazu, Inoue Toshihiro, Kameda Takanori, Kasaoka Nanako, Inoue-Mochita Miyuki, Tsuboi Naoko et al.

Dexamethasone activates the RhoA/ROCK pathway, reducing aqueous outflow and increasing outflow resistance. Blocking this pathway mitigates these steroid-induced glaucoma effects, suggesting a therapeutic target.

Inoue Toshihiro, Kawaji Takahiro, Inatani Masaru, Kameda Takanori, Yoshimura Nagahisa, Tanihara Hidenobu

This study found pseudophakic glaucoma patients have significantly increased aqueous humor proinflammatory cytokines (IL-8, MCP-1), suggesting an altered ocular microenvironment that may influence disease.

Kameda Takanori, Inoue Toshihiro, Inatani Masaru, Fujimoto Tomokazu, Honjo Megumi, Kasaoka Nanako et al.

ROCK inhibitor Y-27632 increased aqueous outflow by disrupting Schlemm's canal cell junctions and actin, improving glaucoma drainage.

Honjo Megumi, Tanihara Hidenobu, Kameda Takanori, Kawaji Takahiro, Yoshimura Nagahisa, Araie Makoto

Y-27632, a ROCK inhibitor, was studied for glaucoma surgery scarring. It inhibited human fibroblast activity and reduced scarring in rabbits, suggesting it could be an effective anti-scarring agent for filtration surgery.